An observational study in Stroke Patients and Tracheostomy, sponsored by Hongying Jiang, MD. Not yet recruiting. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Hongying Jiang, MD · Observational
To evaluate the feasibility of a speaking-valve-based decannulation protocol in tracheostomized stroke patients
Some patients with severe stroke require tracheostomy due to prolonged mechanical ventilation or airway protection. Prolonged use of a tracheostomy tube may lead to a range of complications-including infections, tracheal stenosis, and dysphagia or communication difficulties-which can adversely affect patient recovery and quality of life. Therefore, when patients' respiratory function improves and patients acquire the capability for airway protection, timely and safe removal of the tracheostomy tube constitutes a critical step in the rehabilitation process. The research of the investigators' center has demonstrated that a standardized tracheostomy tube removal protocol based on a speaking valve, implemented by the investigators' rehabilitation team, is associated with successful tube removal in patients with long-term tracheostomies. Accordingly, the investigators intend to evaluate the application of this standardized speaking-valve-based tracheostomy tube removal protocol in stroke patients with tracheostomies, aiming to assess its feasibility and safety in this patient population.
8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.
This study's planned enrollment of 207 is above the median of 152 across 1,968 observational studies indexed under Stroke.
Browse Stroke studies →Hongying Jiang, MD is the lead sponsor of 8 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Tracheostomized stroke patients in stable phase of stroke
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Tracheostomized Stroke Patients
Diagnostic Test: Decannulation Protocol
a Speaking-Valve-Based Decannulation Protocol
Decannulation success rate
(Decannulation - Decannulation failure) / Total number of errolled patients
Time frame: From the date of enrollment to the date of 48 hours after extubation，assessed up to 9months
Time to decannulation
Days from clinically stable to decantation
Time frame: From the date when patients in stable clinical conditions to the date of decannulation，assessed up to 3 months
Reintubation rate
Unplanned reiteration from 48 hours post decannulation to 90 days follow up
Time frame: From 48 hours post decannulation to 90 days follow up
No study locations are listed for this record.
Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.
Of 835 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 12 months is below that.
Counting every sponsor, half of 897 studies reached it within 40 months; a quarter within 18 and three quarters within 85.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hongying Jiang, MD